Rx · Prescription required

Tirzepatide

Mounjaro® · Zepbound®

FDA-approved for type 2 diabetes (Mounjaro®) and for chronic weight management and moderate-to-severe obstructive sleep apnea in adults with obesity (Zepbound®).

Drug class: GIP and GLP-1 receptor agonist
How it is given: Once-weekly injection
Prescription: Required
Dispensed by: DiRx Inc. · licensed pharmacy

FDA status: Brand-name versions (Mounjaro® · Zepbound®) are FDA-approved. If your doctor prescribes a compounded version, it is prepared by a licensed pharmacy for you and is not itself FDA-approved; your doctor and pharmacist explain which version you receive.

Locked

Pricing is shared after you speak with our team and a licensed doctor approves treatment. Clinics see pricing after account verification.

Talk to our team Call (954) 420-7747

Important safety information

Boxed warning: risk of thyroid C-cell tumors. Do not use with a personal or family history of medullary thyroid carcinoma or MEN 2. Common side effects include nausea, diarrhea, vomiting and decreased appetite.

This is not the complete list of risks. Read the full prescribing information and talk to your doctor. Official label (DailyMed) ↗

How to get started

Message us on WhatsApp or call (954) 420-7747.
Talk with a licensed doctor, who reviews your health history and decides if this medicine is right for you.
If prescribed, our team shares pricing and a licensed pharmacy fills your order.

Watch & learn

Videos: how it works and how it is used

Independent videos from doctors, hospitals and health educators on YouTube. They are for general education; your doctor gives the instructions for your treatment.

How to use